Experiment 185624

Worktypes

ANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 30-O-BETA-D-CYMAROPYRANOSIDESARCOSTIN,12-O-ACETYL:METAPLEXIGENINSARCOSTIN,20-O-ACETYL-12-O-CINNAMOYL:SARCOSTIN,12-20-O-DIBENZOYL:CYNANFORIDINSARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL:KIDJOLANINSARCOSTIN,20-O-ACETYL-12-O-NICOTINOYL:PENUPOGENINMETAPLEXIGENIN,12-O-NICOTINOYL-DEACETYL:PENUPOGENIN 3-O-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDESARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDEGAGAMININ

Details

PropertyValue
Pharmacology
CYTOTOXIC ACTIVITY
OrganismLeptadenia hastata (ASCLEPIADACEAE)
CitationAQUINO,R: PIZZA,C: DE TOMMASI,N: DE SIMONE,F:. (1995). NEW POLYOXYPREGNANE ESTER DERIVATIVES FROM LEPTADENIA HASTATA.. 58(5)
Amount utilized
Compound isolated
Dose amount1.0 MCG
Number17
Qualitative resultINACTIVE
AnimalCELL CULTURE
Per unitML
Dose expressionCONC USED